Wezlana (ustekinumab-auub) is a biosimilar for the biologic medication Stelara (ustekinumab). A biosimilar is a U.S. Food and Drug Administration (FDA) approved biologic product that is very similar to an already FDA-approved biologic.
Get your free resource and learn more about:
- How Wezlana works
- People who can take Wezlana
- Common side effects and possible risks
Resource last updated: January 2025